Literature DB >> 10675534

Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes.

Y Fujinaga1, K Inoue, T Nomura, J Sasaki, J C Marvaud, M R Popoff, S Kozaki, K Oguma.   

Abstract

Clostridium botulinum type A hemagglutinin-positive progenitor toxin consists of three distinct components: neurotoxin (NTX), hemagglutinin (HA), and non-toxic non-HA (NTNH). The HA consists of four subcomponents designated HA1, 2, 3a and 3b. By employing purified toxin and GST-fusion proteins of each HA subcomponent, we found that the HA-positive progenitor toxin, GST-HA1 and GST-HA3b bind to human erythrocytes and microvilli of guinea pig upper small intestinal sections. The HA-positive progenitor toxin and GST-HA1 bind via galactose moieties, GST-HA3b binds via sialic acid moieties. GST-2 and GST-3a showed no detectable binding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675534     DOI: 10.1016/s0014-5793(00)01147-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  30 in total

1.  Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patients with dystonia.

Authors:  Hideyuki Arimitsu; Kaoru Inoue; Yoshihiko Sakaguchi; Jaechul Lee; Yukako Fujinaga; Toshihiro Watanabe; Tohru Ohyama; Robert Hirst; Keiji Oguma
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

2.  The botulinum toxin complex meets E-cadherin on the way to its destination.

Authors:  Yo Sugawara; Yukako Fujinaga
Journal:  Cell Adh Migr       Date:  2011-01-01       Impact factor: 3.405

3.  Mass Spectrometric Identification and Differentiation of Botulinum Neurotoxins through Toxin Proteomics.

Authors:  Suzanne R Kalb; John R Barr
Journal:  Rev Anal Chem       Date:  2013-08       Impact factor: 3.067

4.  The genome sequence of Clostridium botulinum type C neurotoxin-converting phage and the molecular mechanisms of unstable lysogeny.

Authors:  Yoshihiko Sakaguchi; Tetsuya Hayashi; Ken Kurokawa; Keisuke Nakayama; Kenshiro Oshima; Yukako Fujinaga; Makoto Ohnishi; Eiichi Ohtsubo; Masahira Hattori; Keiji Oguma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-15       Impact factor: 11.205

Review 5.  Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting.

Authors:  B R Singh
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

6.  Crystallization and preliminary X-ray analysis of the HA3 component of Clostridium botulinum type C progenitor toxin.

Authors:  Toshio Nakamura; Takashi Tonozuka; Mao Kotani; Kanae Obata; Keiji Oguma; Atsushi Nishikawa
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-11-21

7.  Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex.

Authors:  Sho Amatsu; Yo Sugawara; Takuhiro Matsumura; Kengo Kitadokoro; Yukako Fujinaga
Journal:  J Biol Chem       Date:  2013-10-28       Impact factor: 5.157

8.  Differentiation of the gene clusters encoding botulinum neurotoxin type A complexes in Clostridium botulinum type A, Ab, and A(B) strains.

Authors:  Giovanna Franciosa; Francesca Floridi; Antonella Maugliani; Paolo Aureli
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

Review 9.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

Review 10.  Interaction of botulinum toxin with the epithelial barrier.

Authors:  Yukako Fujinaga
Journal:  J Biomed Biotechnol       Date:  2010-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.